Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19

Pharmacogenetics and Genomics
Vishal AgrawalWalter L Miller


All microsomal cytochrome P450s enzymes, including those that metabolize the majority of clinically used drugs, require electron transfer through P450 oxidoreductase (POR). Mutations in human POR cause altered steroidogenesis and congenital malformations, but the clinical effects on drug metabolism are unclear. We examined the effects of POR sequence variants on two drug-metabolizing P450 enzymes, CYP1A2 and CYP2C19. Our previous sequencing of the human POR gene in POR-deficient patients and in 842 normal individuals identified 35 sequence variants. We expressed these 35 POR sequence variants in bacteria, reconstituted them with the CYP enzymes in vitro, and assayed their activities with human CYP1A2 and CYP2C19. POR variants affected the activities of these enzymes to different extents. Disease-causing POR mutations A287P and R457H diminished catalysis by CYP1A2 and CYP2C19 to barely detectable levels. POR A503V, a polymorphism found in 28% of alleles in the normal population, had 85% of wild-type activity with CYP1A2 and 113% of wild-type activity with CYP2C19. Q153R, a disease-causing mutation that severely impaired steroidogenic activity and cytochrome c reduction, increased the activity of CYP1A2 to 144% and CYP2C19 activi...Continue Reading


Oct 1, 1984·Archives of Biochemistry and Biophysics·G T Miwa, A Y Lu
Jan 1, 1980·American Journal of Medical Genetics·C D DeLozierE Engel
Jan 1, 1997·Clinical Dysmorphology·G CrisponiM E Piu
Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·M WangJ J Kim
Oct 16, 1999·Science·William E Evans, M V Relling
Mar 10, 2001·Protein Expression and Purification·A S SaribasL Waskell
May 24, 2001·The Journal of Biological Chemistry·P A HubbardJ J Kim
Nov 17, 2001·JAMA : the Journal of the American Medical Association·K A PhillipsW Sadee
May 9, 2002·Drug Metabolism Reviews·Slobodan Rendic
Feb 5, 2003·The Journal of Biological Chemistry·Colin HendersonC Roland Wolf
May 3, 2003·Pharmacology & Therapeutics·Wayne L Backes, Rusty W Kelley
Dec 19, 2003·Protein Expression and Purification·Dongmei ChengWayne L Backes
Apr 6, 2004·Trends in Pharmacological Sciences·Magnus Ingelman-Sundberg
Apr 20, 2004·Assay and Drug Development Technologies·Bryan D MarksOlga V Trubetskoy
May 28, 2004·Nature·William E Evans, M V Relling
Jul 9, 2004·Drug Metabolism Reviews·F Peter Guengerich
Jul 21, 2004·American Journal of Medical Genetics. Part a·Masanori AdachiAkira Oka
Mar 19, 2005·Endocrinology·Walter L Miller
Jul 5, 2005·Toxicology and Applied Pharmacology·Magnus Ingelman-Sundberg
Oct 26, 2005·Biochemical and Biophysical Research Communications·Bettie Sue Masters
Nov 29, 2005·Toxicology Letters·Ingolf Cascorbi
Jan 18, 2006·Annual Review of Medicine·Michel EichelbaumWilliam E Evans
Sep 26, 2006·The Journal of Biological Chemistry·Christopher C MarohnicBettie Sue Masters
Nov 23, 2006·Annals of Internal Medicine·D M RodenPharmacogenetics Research Network
Dec 29, 2006·Chemistry & Biodiversity·Bernard Testa, Stefanie D Krämer
Mar 3, 2007·Pharmaceutical Research·Lilian G YengiJohn Kao
Mar 7, 2007·Clinical Pharmacology and Therapeutics·Kathleen M GiacominiPharmacogenetics Research Network
Mar 21, 2007·Chemistry & Biodiversity·Bernard Testa, Stefanie D Krämer
Mar 29, 2007·The Journal of Clinical Endocrinology and Metabolism·Rachel R ScottWalter L Miller
Jun 28, 2007·Molecular Endocrinology·Amit V PandeyChrista E Flück
Jan 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ningwu HuangWalter L Miller
Feb 9, 2008·Hormone Research·Rachel R Scott, Walter L Miller


Jun 6, 2013·Applied Biochemistry and Biotechnology·Ina NeunzigMatthias Bureik
Jun 19, 2009·Pharmacogenetics and Genomics·Sarah C SimMagnus Ingelman-Sundberg
Aug 11, 2010·Pharmacogenetics and Genomics·Vishal AgrawalWalter L Miller
Nov 4, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Christopher C MarohnicMichel Kranendonk
Jan 19, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Daniela MoutinhoMichel Kranendonk
Apr 10, 2008·The Journal of Clinical Endocrinology and Metabolism·Larissa G GomesWalter L Miller
Oct 30, 2008·The Journal of Clinical Endocrinology and Metabolism·Larissa G GomesWalter L Miller
Oct 20, 2009·The Journal of Clinical Endocrinology and Metabolism·Taninee SahakitrungruangWalter L Miller
Sep 17, 2010·European Journal of Endocrinology·Dorota Tomalik-ScharteWiebke Arlt
Nov 19, 2010·Drug Metabolism and Pharmacokinetics·Yoshiro SaitoTomohide Tamura
Jan 29, 2013·Pharmacology & Therapeutics·Amit V Pandey, Christa E Flück
Aug 25, 2010·Biochemical and Biophysical Research Communications·Amit V PandeyPrimus E Mullis
Mar 2, 2010·Molecular and Cellular Endocrinology·Catherine NicoloAmit V Pandey
Aug 19, 2014·Chemical Research in Toxicology·Sylvie E Kandel, Jed N Lampe
Jun 3, 2014·Pharmacology & Therapeutics·Payman ShahabiSophie Visvikis-Siest
Nov 13, 2010·Molecular and Cellular Endocrinology·Walter L MillerKathleen M Giacomini
Aug 17, 2011·Biochemical and Biophysical Research Communications·Christa E FlückAmit V Pandey
Oct 22, 2008·Molecular and Cellular Endocrinology·Walter L MillerKathleen M Giacomini
Sep 17, 2014·Molecular and Cellular Endocrinology·Walter L Miller, Meng Kian Tee
Feb 26, 2015·Pharmacogenomics·Mária TomkováPavel Martásek
May 23, 2014·Frontiers in Pharmacology·Amit V Pandey, Patrick Sproll
Oct 27, 2017·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Tianran SongHaixiang Sun
Oct 14, 2010·Pharmacogenetics and Genomics·Duanpen SandeeWalter L Miller
Oct 11, 2012·Pharmacogenetics and Genomics·Lei HuLan Fan
Jul 11, 2015·The Journal of Biological Chemistry·Valerie M KramlingerF Peter Guengerich
Feb 16, 2020·The Journal of Clinical Endocrinology and Metabolism·Shaheena ParweenAmit V Pandey
Sep 26, 2013·Therapeutic Drug Monitoring·Laure ElensRon H N van Schaik
May 29, 2014·Drug Metabolism and Drug Interactions·Yao YangStuart A Scott
Oct 4, 2013·Therapeutic Drug Monitoring·Violette M G J GijsenSaskia N de Wildt
Jan 18, 2013·Pharmacogenetics and Genomics·Laure ElensRon H N van Schaik
Apr 14, 2016·The Journal of Steroid Biochemistry and Molecular Biology·Fabian Z BurkhardAmit V Pandey

Related Concepts

CYP2C19 protein, human
CYP1A2 protein, human
Xenobiotic Monooxygenases
Plasma Membrane
Enzyme Activation
Alkalescens-Dispar Group
Metabolic Detoxication, Drug
NADPH-Ferrihemoprotein Reductase

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Laryngeal Neoplasms

Laryngeal Neoplasms occur in the Larynx and are typically associated with smoking and alcohol consumption. Discover the latest research on Laryngeal Neoplasms here.

Cell Atlas Along the Gut-Brain Axis

Profiling cells along the gut-brain axis at the single cell level will provide unique information for each cell type, a three-dimensional map of how cell types work together to form tissues, and insights into how changes in the map underlie health and disease of the GI system and its crosstalk with the brain. Disocver the latest research on single cell analysis of the gut-brain axis here.